drugset / Trial / NCT03436394
Effect of Renal Impairment on Evobrutinib Pharmacokinetics (PK)
Non-randomizedParallel-groupOpen-labelOther
Summary
The study will investigate the PK and safety of evobrutinib in subjects with different degree of renal impairment as compared to subjects with normal renal function.
Timeline
- Start
- 2018-03-21
- Primary completion
- 2019-02-22
- Completion
- 2019-02-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Evobrutinib | Small molecule | — | Oral |